Gradient Investments LLC Cytosorbents Corp Transaction History

Gradient Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 18, 2021	SELL	$7.0 - $9.71 $1,050 - $1,456	-150 Closed	0 $0
Q2 2021 Jul 12, 2021	SELL	$7.55 - $9.42 $7,927 - $9,891	-1,050 Reduced 87.5%	150 $1,000
Q1 2021 Apr 21, 2021	BUY	$8.23 - $11.48 $9,876 - $13,776	1,200 New	1,200 $10,000
Q2 2020 Jul 10, 2020	SELL	$6.28 - $10.59 $9,420 - $15,885	-1,500 Closed	0 $0
Q1 2020 Apr 07, 2020	BUY	$3.77 - $7.73 $5,655 - $11,595	1,500 New	1,500 $12,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $37.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Gradient Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Investments LLC with notifications on news.